-

Hims & Hers Launches Health Collective and Community Member Council

Customer-led programs give customers a leading voice in their health and wellness journey

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced two new programs dedicated to serving its customers in even more personalized ways, encouraging customers to play an active role in the decisions and choices that shape their healthcare experience.

The two groups, the Hims & Hers Health Collective, and the Hims & Hers Community Member Council, are born from the company’s mission to help the world feel great through the power of better health and its commitment to building a long-term relationship with each individual customer that seeks care at Hims & Hers.

The Hims & Hers Health Collective is a community-driven ambassador program that allows Hims & Hers customers to connect with and support other members on their health and wellness journeys. By sharing their stories with Hims & Hers and their community, Health Collective members can celebrate their progress and achievements as well as help new customers understand the benefits of seeking healthcare on the platform. Members also have the opportunity to be the first to learn about new products.

The Health Collective is an application-based program available to any active customer across any category on the Hims & Hers platform.

The Hims & Hers Community Member Council is an exclusive group of 15 Hims & Hers members hand-selected to help shape and influence the future of the Hims & Hers platform. The Council’s feedback and insights will help inform the development of products, services, and experiences across the Hims & Hers platform. This select group will collaborate directly with Hims & Hers teams and serve as the trusted voice and representatives of Hims & Hers customers everywhere.

“At Hims & Hers, we’re successful when our customers are. The long-term success and wellbeing of each individual customer is at the center of everything we do,” says Mike Chi, Chief Commercial Officer for Hims & Hers. “By partnering with and listening to our customers’ needs, we are able to make even better improvements to their experience and care. We are not just changing how healthcare works—we are helping to build a system that truly serves the people it was meant to help.”

To apply to the Hims & Hers Health Collective or to learn more, visit https://www.hims.com/health-collective or https://www.forhers.com/health-collective

To learn more about the Hims & Hers Community Member Council, visit https://www.hims.com/community-member-council-page or https://www.forhers.com/community-member-council-page

Contacts

Press Contact
Tanner Mangum
press@forhims.com

Hims & Hers

NYSE:HIMS

Release Versions

Contacts

Press Contact
Tanner Mangum
press@forhims.com

More News From Hims & Hers

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers’ first international generic GLP-1 offering, demonstrating the company’s ability to meet the unique needs of each global market it serves while continuing its international expansion efforts. Personalized treatment plans are available starting at $149 CAD/month, making...

Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform for eligible customers in Canada. This makes affordable GLP-1 treatment accessible to Canadians for whom cost has long been a barrier to treatment. For eligible customers, personalised treatment plans are available starting at $149/month CAD. GLP-1 treatments have transformed obesity and metabolic health, with...

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $350 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced of...
Back to Newsroom